Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Learn the telltale signs you should revise your budget, including income changes, expense spikes, and shifting priorities.
24,979 articlesA tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Marvell is signaling rapid growth in its custom chips for AI accelerators. This article breaks down the forecast, wha...
Markets paused their march higher at midday as tech leadership shines and geopolitical headwinds test appetite. Marve...
Investors chase the next big energy winner as AI drives data centers demand. Oklo presents a high-risk, high-puture o...
Wall Street and crypto traders watch a quiet moment for Bitcoin as geopolitical tensions cool and ETF inflows grow. T...
In early 2026, Tutor Perini faced a mix of growth opportunities and project-level headwinds. This article breaks down...
As market volatility persists, a three-fund, monthly-payer strategy aims to deliver around $9,000 annual passive inco...
As the clean energy shift accelerates, two hydrogen-focused leaders—Bloom Energy and Plug Power—offer distinct paths ...
A closer look at how Lawrence Calcano built iCapital into a leading wealth-tech platform for alternatives. Learn the ...
A May crackdown on public-assistance fraud in Florida pushed total dubious benefits over $806,000, as authorities ann...
A major institutional bet lands on Birkenstock. Rice Hall James loads 466,577 shares, a roughly $19.8 million stake i...
As rates stay elevated in 2026, lenders are weighing unusual signals beyond credit scores. This report outlines the w...